Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years

Rincon, Natalie L.; McDowell, Kelsey Rae; Weatherspoon, Darien; Ritchwood, Tiarney D.; Rocke, Daniel J.; Adjei Boakye, Eric; Osazuwa-Peters, Nosayaba

doi:10.1080/21645515.2024.2313249

Cited by 3 publications

(1 citation statement)

References 48 publications

(68 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent publications, including those by Rincon et al in your journal, have illuminated concerning disparities in human papillomavirus (HPV) vaccine uptake among U.S. adults aged 27–45 years, particularly among minority populations. 1 This letter proposes multilayered strategies to address these disparities, drawing on effective public health interventions from various global contexts.…”

Section: Dear Editormentioning

confidence: 99%

Comment on “Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years”

Zaidi,

Alghalyini

2024

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Section: Dear Editormentioning

confidence: 99%

Comment on “Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years”

Zaidi,

Alghalyini

2024

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Pap test recency and HPV vaccination among Brazilian immigrant women in the United States: a cross-sectional study

Greaney,

Cohen,

Allen

2024

BMC Public Health

View full text Add to dashboard Cite

Background The United States (U.S.) has a growing population of Brazilian immigrant women. However, limited research has explored Pap tests and human papillomavirus (HPV) vaccination among this population. Methods Participants completed an online survey between July—August 2020. Bivariate analyses examined associations between healthcare-related variables (e.g., insurance, having a primary care provider) and demographics (e.g., age, education, income, marital status, years living in the U.S., primary language spoken at home) with 1) Pap test recency (within the past 3 years) and 2) HPV vaccination (0 doses vs. 1 + doses). Variables significant at p < 0.10 in bivariate analyses were included in multivariable logistic regression models examining Pap test recency and HPV vaccination. Results The study found that 83.7% of the sample had a Pap test in the past three years. Women who did not know their household income were less likely to be than women who reported a household income of < $25,000 (adjusted OR [aOR] = 0.34, 95% CI: 0.12, 0.95). Women who had seen a healthcare provider in the past year were more likely to have had a Pap test within the last three years than those who had not seen a provider in the past year ([aOR] = 2.43, 95% CI: 1.32, 4.47). Regarding HPV vaccination, 30.3% of respondents reported receiving one or more doses of the HPV vaccine. The multivariable logic regression models determined that women aged 27 -45 (aOR = 0.35, 95% CI: 0.18, 0.67) were less likely than women aged 18–26 to have been vaccinated against HPV). and that women with a PCP were more likely to be vaccinated than those without a PCP (aOR = 2.47. 95% CI:1.30, 4.59). Conclusion This study found that Brazilian immigrant women in the youngest age groups (21 – 29) for Pap test, 18- 26 for HPV vaccination) had somewhat better rates of Pap screening and HPV vaccination than the general U.S. population. This study adds new information about cervical cancer prevention and control behaviors among Brazilian immigrant women.

show abstract

Demographic Influences on Adult HPV Vaccination: Results from a Cross-Sectional Survey in Tennessee

Cernasev,

Oyedeji,

Springer

et al. 2024

Healthcare

View full text Add to dashboard Cite

HPV is the most prevalent sexually transmitted infection in the U.S., with more than 80% of all Americans contracting it by age 45. Effective vaccines for HPV exist and were recently approved for adults aged 27–45 years, though uptake remains low in all age groups, particularly in Tennessee where 1089 cancers were attributed to HPV in 2020. Between 29 June and 17 August 2023, we conducted a cross-sectional survey to gain insights about the barriers and facilitators of HPV in 2011 adults aged 18 to 45 years in Tennessee. We developed our survey based on previous instruments to understand predictors of HPV vaccination in adults. Using descriptive statistics and bivariate and logistic regression analyses, we found higher vaccination rates in females, participants aged 18–38 years, participants with a high school education or higher, Hispanic or Latine individuals, and participants identifying as moderate or liberal. These insights highlight the need for public health interventions that consider demographic differences to successfully increase vaccination rates and reduce HPV-associated cancer risk.

show abstract

Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years

Cited by 3 publications

References 48 publications

Comment on “Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years”

Comment on “Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years”

Pap test recency and HPV vaccination among Brazilian immigrant women in the United States: a cross-sectional study

Demographic Influences on Adult HPV Vaccination: Results from a Cross-Sectional Survey in Tennessee

Contact Info

Product

Resources

About